Trial Profile
Success of Alternative Therapies in Chronic Urticaria Patients Failing Omalizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2016
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary) ; Ciclosporin; Mycophenolate mofetil; Sirolimus; Tacrolimus
- Indications Urticaria
- Focus Therapeutic Use
- 15 Mar 2016 New trial record